Abstract:Inflammation is an innate immune response to infection, and it is the main factor causing bodily injury and other complications in the pathological process. Ginsenoside Rh4 (G-Rh4), a minor ginsenoside of Panax ginseng C. A. Meyer and Panax notoginseng, has excellent pharmacological properties. However, many of its major pharmacological mechanisms, including anti-inflammatory actions, remain unrevealed. In this study, network pharmacology and an experimental approach were employed to elucidate the drug target and pathways of G-Rh4 in treating inflammation. The potential targets of G-Rh4 were selected from the multi-source databases, and 58 overlapping gene symbols related to G-Rh4 and inflammation were obtained for generating a protein–protein interaction (PPI) network. Molecular docking revealed the high affinities between key proteins and G-Rh4. Gene ontology (GO) and pathway enrichment analyses were used to analyze the screened core targets and explore the target–pathway networks. It was found that the JAK-STAT signaling pathway, TNF signaling pathway, NF-κB signaling pathway, and PI3K-Akt signaling pathway may be the key and main pathways of G-Rh4 to treat inflammation. Additionally, the potential molecular mechanisms of G-Rh4 predicted from network pharmacology analysis were validated in RAW264.7 cells. RT-PCR, Western blot, and ELISA analysis indicated that G-Rh4 significantly inhibited the production of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β, as well as inflammation-related enzymes in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Moreover, in vitro experiments evaluated that Ginsenoside Rh4 exerts anti-inflammatory effects via the NF-κB and STAT3 signaling pathways. It is believed that our study will provide the basic scientific evidence that G-Rh4 has potential anti-inflammatory effects for further clinical studies.

Inhibitory Effects of Sulfated 20(S)-Ginsenoside Rh2 on the Release of Pro-Inflammatory Mediators in LPS-induced RAW 264.7 Cells.

Sulfated Derivative of 20(S)-Ginsenoside Rh2 Inhibits Inflammatory Cytokines Through MAPKs and NF-kappa B Pathways in LPS-Induced RAW264.7 Macrophages

Sulfated Derivatives of 20(S)-Ginsenoside Rh2 and Their Inhibitory Effects on LPS-induced Inflammatory Cytokines and Mediators.

Ginsenoside Rh2 Alleviates LPS-Induced Inflammatory Responses by Binding to TLR4/MD-2 and Blocking TLR4 Dimerization

Ginsenoside Rh2 Downregulates LPS-Induced NF-κB Activation Through Inhibition of TAK1 Phosphorylation in RAW 264.7 Murine Macrophage

Ginsenoside Rk1 Suppresses Pro-Inflammatory Responses in Lipopolysaccharide-Stimulated Raw264.7 Cells by Inhibiting the Jak2/Stat3 Pathway

Protective effects of ginsenoside-Rg2 and -Rh1 on liver function through inhibiting TAK1 and STAT3-mediated inflammatory activity and Nrf2/ARE-mediated antioxidant signaling pathway

Protective Effect of Ginsenosides Rg1 and Re on Lipopolysaccharide-Induced Sepsis by Competitive Binding to Toll-like Receptor 4.

Ginsenoside Rb1 Exerts Anti-Inflammatory Effects in Vitro and in Vivo by Modulating Toll-Like Receptor 4 Dimerization and NF-kB/MAPKs Signaling Pathways.

Ginsenoside Rh2-B1 Stimulates Cell Proliferation and IFN-γ Production by Activating the P38 MAPK and ERK-dependent Signaling Pathways in CTLL-2 Cells.

Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4

Anti-Inflammatory Effects of Ginsenoside Rb3 in LPS-Induced Macrophages Through Direct Inhibition of TLR4 Signaling Pathway

Lipopolysaccharide-induced Inflammation is Inhibited by Ginsenoside Re Through NF-kappa B Signaling in RAW264.7 Cells and Primary Rat Hepatocytes

Ginsenoside-Rd Exhibits Anti-Inflammatory Activities Through Elevation Of Antioxidant Enzyme Activities And Inhibition Of Jnk And Erk Activation In Vivo

Ginsenoside Rh2 Attenuates Allergic Airway Inflammation By Modulating Nuclear Factor-Kappa B Activation In A Murine Model Of Asthma

Ginsenoside Rb1 Ameliorates Staphylococcus Aureus-Induced Acute Lung Injury Through Attenuating NF-κB and MAPK Activation.

Anti-inflammatory Effects of Ganoderma Lucidum Sterols Via Attenuation of the P38 MAPK and NF-κB Pathways in LPS-induced RAW 264.7 Macrophages

Suppression of MAPKs/NF-κB Activation Induces Intestinal Anti-Inflammatory Action of Ginsenoside Rf in HT-29 and RAW264.7 Cells

Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia.

Inhibitory Effect of Ginsenoside-Rd on Carrageenan-Induced Inflammation in Rats

Ginsenoside Rg1 Improves Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Inflammatory Responses and Modulating Infiltration of M2 Macrophages